# Ribociclib

## Kisqali 200mg

*藥物代碼*：OKIS

*給藥途徑*：O

*用法用量*：

Breast cancer, advanced or metastatic: Females (HR-positive, HER-2 negative): Oral: 600 mg once daily for 21 days, followed by a 7-day rest period to complete a 28-day treatment cycle (in combination with continuous letrozole, continue until disease progression or unacceptable toxicity.

## Kisqali 200mg 63#-盒(sample)

*藥物代碼*：OKIS0

*給藥途徑*：O

*用法用量*：

Breast cancer, advanced or metastatic: Females (HR-positive, HER-2 negative): Oral: 600 mg once daily for 21 days, followed by a 7-day rest period to complete a 28-day treatment cycle (in combination with continuous letrozole, continue until disease progression or unacceptable toxicity.

